Position in DSGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,137,421
+$978,428 QoQ
Shares Held
147,714
+35.6% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 136 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Derivatives in DSGN
reported options exposure · as of Mar 31, 2023CallValue
$200,219
CallShares
34,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. DSGN ranks #210 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in DSGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,137,421 | 147,714 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,158,993 | 108,928 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,696,523 | 180,866 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $518,237 | 68,823 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $339,633 | 87,988 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $1,115,042 | 207,257 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,046,190 | 610,803 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,952,406 | 484,468 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,113,166 | 420,063 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,957,572 | 829,480 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,763,237 | 279,879 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $200,219 | 34,700 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $4,559,529 | 790,213 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,302,480 | 516,811 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $721,278 | 70,300 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $2,365,846 | 141,498 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $668,800 | 40,000 | Call | Sole | 2022-11-14 | |
| 2021-09-30 | $208,142 | 14,169 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $7,565,806 | 253,037 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||